| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,607 |
30,985 |
$738K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,180 |
9,152 |
$490K |
| S9083 |
Global fee urgent care centers |
6,898 |
6,267 |
$379K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,134 |
5,667 |
$366K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,608 |
5,454 |
$175K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
124 |
124 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,033 |
2,928 |
$2K |
| 99215 |
Prolong outpt/office vis |
26 |
25 |
$1K |
| 81003 |
|
9,220 |
8,955 |
$908.68 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
25 |
$531.46 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
955 |
933 |
$174.57 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
71 |
71 |
$88.50 |
| 85018 |
|
730 |
720 |
$80.13 |
| 94760 |
|
4,593 |
4,499 |
$70.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
569 |
538 |
$61.76 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
220 |
215 |
$58.70 |
| 82947 |
|
101 |
100 |
$36.12 |
| 92562 |
|
230 |
229 |
$28.58 |
| 81025 |
|
27 |
27 |
$5.60 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$5.01 |
| 3079F |
|
1,673 |
1,610 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
425 |
411 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
513 |
493 |
$0.00 |
| 3080F |
|
257 |
248 |
$0.00 |
| 3074F |
|
3,655 |
3,436 |
$0.00 |
| 3075F |
|
824 |
805 |
$0.00 |
| 1220F |
|
37 |
36 |
$0.00 |
| 3008F |
|
40 |
39 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
28 |
28 |
$0.00 |
| 99422 |
|
15 |
14 |
$0.00 |
| 3077F |
|
429 |
413 |
$0.00 |
| 3078F |
|
3,061 |
2,901 |
$0.00 |
| 97803 |
|
174 |
174 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,841 |
1,743 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
94 |
91 |
$0.00 |
| 99173 |
|
272 |
271 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
28 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
13 |
$0.00 |